Importantly, it is a canonical pathway involved in first-line treatments of multiple sclerosis as a main target of the IFN system [25] but, also, affects different complex pathways, involving processes such as differentiation, proliferation or survival and cell death [26,27]. Here, IFNA1 is linked to multiple sclerosis.